LEADER 01272nam  2200457   450 
001 9910583485503321
005 20180322232821.0
010   $a0-12-813428-3
035   $a(CKB)3710000001410628
035   $a(MiAaPQ)EBC4882842
035   $a(PPN)220306125
035   $a(EXLCZ)993710000001410628
100   $a20170715h20172017  uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aPiperidine-based drug discovery /$fRuben Vardanyan
210  1$aAmsterdam, Netherlands :$cElsevier,$d2017.
210  4$dİ2017
215   $a1 online resource (359 pages) $cillustrations
225 1 $aHeterocyclic Drug Discovery Series
300   $aIncludes indexes.
311   $a0-12-805157-4 
410  0$aHeterocyclic drug discovery series.
606   $aDrugs$xDesign
606   $aDrug development
606   $aPiperidine
615  0$aDrugs$xDesign.
615  0$aDrug development.
615  0$aPiperidine.
676   $a615.19
700   $aVardanyan$b R?uben$0722711
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910583485503321
996   $aPiperidine-based drug discovery$91988357
997   $aUNINA